Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A promising measure to prevent HPV-positive oral squamous cell carcinoma

A promising measure to prevent HPV-positive oral squamous cell carcinoma The article “HPV and oral squamous cell carcinoma: a review of HPV-positive OSCC and possible strategies for future” provides inspiring insights into the association between human papillomavirus (HPV) infection and oral squamous cell carcinoma (OSCC), as well as the possible strategies that we can adopt in future to minimize its health impact on the population [1]. This association has been widely recognized in recent years, particularly, for the high-risk HPV 16 and 18 strains. The cancer-inducing proteins E6 and E7 of HPV have been identified to be the main factors that inhibit the tumor suppressors p53 and retinoblastoma protein (pRb), contributing to the development of OSCC. It also has been confirmed that HPV infection is associated with OSCC prognosis. Compared to HPV-negative OSCC patients, HPV-positive OSCC patients have a better prognosis [2].At present, there is no suitable OSCC HPV infection detection method approved by the health administration. Potential methods include immunohistochemical detection of p16 expression, polymerase chain reaction (PCR), or in situ hybridization detection method, which are used to indirectly reflect the HPV infection status. Due to the ineffectiveness of these methods, there are no HPV infection status screening programs for the OSCC high-risk group. Therefore, developing effective HPV http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Infection International de Gruyter

A promising measure to prevent HPV-positive oral squamous cell carcinoma

Zhang, Songfa; Jiang, Shan; Zang, Xiao
Infection International , Volume 6 (1): 2 – Nov 28, 2017
Download PDF
2 pages

Loading next page...
 
/lp/de-gruyter/a-promising-measure-to-prevent-hpv-positive-oral-squamous-cell-arh0kC55v0
Publisher
de Gruyter
Copyright
© 2017 Walter de Gruyter GmbH, Berlin/Boston
eISSN
2544-0349
DOI
10.1515/ii-2017-0156
Publisher site
See Article on Publisher Site

Abstract

The article “HPV and oral squamous cell carcinoma: a review of HPV-positive OSCC and possible strategies for future” provides inspiring insights into the association between human papillomavirus (HPV) infection and oral squamous cell carcinoma (OSCC), as well as the possible strategies that we can adopt in future to minimize its health impact on the population [1]. This association has been widely recognized in recent years, particularly, for the high-risk HPV 16 and 18 strains. The cancer-inducing proteins E6 and E7 of HPV have been identified to be the main factors that inhibit the tumor suppressors p53 and retinoblastoma protein (pRb), contributing to the development of OSCC. It also has been confirmed that HPV infection is associated with OSCC prognosis. Compared to HPV-negative OSCC patients, HPV-positive OSCC patients have a better prognosis [2].At present, there is no suitable OSCC HPV infection detection method approved by the health administration. Potential methods include immunohistochemical detection of p16 expression, polymerase chain reaction (PCR), or in situ hybridization detection method, which are used to indirectly reflect the HPV infection status. Due to the ineffectiveness of these methods, there are no HPV infection status screening programs for the OSCC high-risk group. Therefore, developing effective HPV

Journal

Infection International – de Gruyter

Published: Nov 28, 2017

References

  • The feminization of HPV: how science, politics, economics and gender norms shaped US HPV vaccine implementation
  • Head and neck cancers: clinical practice guidelines
  • Head and neck cancers: clinical practice guidelines
  • HPV and oral squamous cell carcinoma: a review of HPV-positive OSCC and possible strategies for future
  • HPV and oral squamous cell carcinoma: a review of HPV-positive OSCC and possible strategies for future
  • The feminization of HPV: how science, politics, economics and gender norms shaped US HPV vaccine implementation